SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000906709-19-000006
Filing Date
2019-08-09
Accepted
2019-08-08 20:26:01
Documents
54
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nktr2019-06x30x10q.htm   iXBRL 10-Q 1344100
2 EXHIBIT 31.1 nktr2019-06x30xexx311.htm EX-31.1 12131
3 EXHIBIT 31.2 nktr2019-06x30xexx312.htm EX-31.2 12158
4 EXHIBIT 32.1 nktr2019-06x30xexx321.htm EX-32.1 8135
  Complete submission text file 0000906709-19-000006.txt   5513617

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nktr-20190630.xsd EX-101.SCH 46353
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nktr-20190630_cal.xml EX-101.CAL 68209
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nktr-20190630_lab.xml EX-101.LAB 566275
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nktr-20190630_pre.xml EX-101.PRE 306658
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nktr-20190630_def.xml EX-101.DEF 181131
10 EXTRACTED XBRL INSTANCE DOCUMENT nktr2019-06x30x10q_htm.xml XML 731666
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 191011071
SIC: 2834 Pharmaceutical Preparations